The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook 2024
Synopsis
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at US$ 161 million in 2020 and is expected to reach US$ 288.6 million by the end of 2027, growing at a CAGR of 8.8% during 2021-2027.
This report focuses on ICAD (Intracranial Atherosclerotic Disease) Pathology volume and value at the global level, regional level and company level. From a global perspective, this report represents overall ICAD (Intracranial Atherosclerotic Disease) Pathology market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at US$ 161 million in 2020 and is expected to reach US$ 288.6 million by the end of 2027, growing at a CAGR of 8.8% during 2021-2027.
This report focuses on ICAD (Intracranial Atherosclerotic Disease) Pathology volume and value at the global level, regional level and company level. From a global perspective, this report represents overall ICAD (Intracranial Atherosclerotic Disease) Pathology market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis
Index1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
1.1 Product Overview and Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology
1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Stent
1.2.3 PTA Balloon
1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Estimates and Forecasts
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2016-2027
1.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2016-2027
1.4.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region: 2016 Versus 2021 Versus 2027
2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competition by Manufacturers
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers (2016-2021)
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturers (2016-2021)
2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Manufacturers (2016-2021)
2.4 Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Sites, Area Served, Product Type
2.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Situation and Trends
2.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue
2.5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ICAD (Intracranial Atherosclerotic Disease) Pathology Retrospective Market Scenario by Region
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
3.3.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
3.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Region
3.5.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region
3.5.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.6.1 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
3.6.2 Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country
3.7.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
3.7.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Analysis by Type
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2016-2021)
4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2016-2021)
5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Analysis by Application
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021)
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2016-2021)
5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Stryker
6.1.1 Stryker Corporation Information
6.1.2 Stryker Description and Business Overview
6.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.1.5 Stryker Recent Developments/Updates
6.2 Balt
6.2.1 Balt Corporation Information
6.2.2 Balt Description and Business Overview
6.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.2.5 Balt Recent Developments/Updates
6.3 TERUMO
6.3.1 TERUMO Corporation Information
6.3.2 TERUMO Description and Business Overview
6.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
6.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.3.5 TERUMO Recent Developments/Updates
6.4 MicroPort
6.4.1 MicroPort Corporation Information
6.4.2 MicroPort Description and Business Overview
6.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
6.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.4.5 MicroPort Recent Developments/Updates
6.5 Acandis
6.5.1 Acandis Corporation Information
6.5.2 Acandis Description and Business Overview
6.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
6.5.5 Acandis Recent Developments/Updates
7 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Cost Analysis
7.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
7.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
8.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
9 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
9.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
9.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Growth Drivers
9.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
9.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
10 Global Market Forecast
10.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of ICAD (Intracranial Atherosclerotic Disease) Pathology by Type (2022-2027)
10.1.2 Global Forecasted Revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology by Type (2022-2027)
10.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application (2022-2027)
10.2.2 Global Forecasted Revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application (2022-2027)
10.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of ICAD (Intracranial Atherosclerotic Disease) Pathology by Region (2022-2027)
10.3.2 Global Forecasted Revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) Comparison by Application (2021-2027)
Table 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Covered in This Study
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers (2016-2021)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Sites and Area Served
Table 11. Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2016-2021) & (Units)
Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2016-2021)
Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units)
Table 19. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021)
Table 20. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021)
Table 22. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units)
Table 23. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021)
Table 24. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2016-2021)
Table 30. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units)
Table 31. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021)
Table 32. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2016-2021)
Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Type (2016-2021)
Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2016-2021)
Table 40. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million US$) by Type (2016-2021)
Table 41. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2016-2021)
Table 42. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Type (2016-2021)
Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Application (2016-2021)
Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2016-2021)
Table 45. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million US$) by Application (2016-2021)
Table 46. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2016-2021)
Table 47. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit) by Application (2016-2021)
Table 48. Stryker Corporation Information
Table 49. Stryker Description and Business Overview
Table 50. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 52. Stryker Recent Developments/Updates
Table 53. Balt Corporation Information
Table 54. Balt Description and Business Overview
Table 55. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 57. Balt Recent Developments/Updates
Table 58. TERUMO Corporation Information
Table 59. TERUMO Description and Business Overview
Table 60. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 62. TERUMO Recent Developments/Updates
Table 63. MicroPort Corporation Information
Table 64. MicroPort Description and Business Overview
Table 65. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 67. MicroPort Recent Developments/Updates
Table 68. Acandis Corporation Information
Table 69. Acandis Description and Business Overview
Table 70. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 72. Acandis Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
Table 76. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List
Table 77. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
Table 78. ICAD (Intracranial Atherosclerotic Disease) Pathology Growth Drivers
Table 79. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
Table 80. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
Table 81. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2022-2027) & (Units)
Table 82. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Type (2022-2027)
Table 83. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 84. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Type (2022-2027)
Table 85. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2022-2027) & (Units)
Table 86. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Application (2022-2027)
Table 87. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 88. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Application (2022-2027)
Table 89. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2022-2027) & (Units)
Table 90. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Region (2022-2027)
Table 91. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 92. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Region (2022-2027)
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type in 2020 & 2027
Figure 3. Stent Product Picture
Figure 4. PTA Balloon Product Picture
Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size 2016-2027 (US$ Million)
Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2016-2027 (Units)
Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturers in 2020
Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest ICAD (Intracranial Atherosclerotic Disease) Pathology Players: Market Share by Revenue in 2020
Figure 16. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2016-2021)
Figure 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region in 2020
Figure 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2016-2021)
Figure 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region in 2020
Figure 21. U.S. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Type (2016-2021)
Figure 46. Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application (2016-2021)
Figure 47. Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application in 2020
Figure 48. Revenue Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application (2016-2021)
Figure 49. Revenue Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Application in 2020
Figure 50. Manufacturing Cost Structure of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 51. Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 52. ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
